Login
Editor’s note: Here’s an excerpt from an article in The BMJ. To read the piece in its entirety, click here.
On Sept. 13 the UK chief medical officers recommended that all 12-15 year olds be offered a single dose of Pfizer-BioNTech COVID-19 vaccine. This followed a previous recommendation by the Joint Committee on Vaccination and Immunisation not to offer COVID-19 vaccines to healthy 12-15 year olds.
The UK now joins a growing list of countries offering vaccination to those aged 12 and over, but it is providing only one dose rather than the two given in other countries because of concerns about rare side effects such as heart inflammation.
The health benefits of COVID-19 vaccination are small in this age group since COVID-19 infection is not a serious threat to their health. However, the chief medical officers’ decision was influenced by the wider benefit of reducing further disruption to education.
Parents are understandably concerned about vaccine safety. It’s not yet clear how schools and healthcare professionals will cope with delivering up to 2.6 million COVID-19 vaccines, answering parents’ questions and supporting teenagers to make informed decisions.
Read the entire The BMJ article here.
